Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18228
Country/Region: Cameroon
Year: 2016
Main Partner: Not Available
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Pediatric Care and Support (PDCS) $135,582
Testing: HIV Testing and Counseling (HVCT) $304,211
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $321,853
Treatment: Adult Treatment (HTXS) $899,978
Treatment: Pediatric Treatment (PDTX) $1,149,824
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 33,322
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 12,086
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 39,119
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 15,154
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 106,081
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 34,992
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 50,819
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 19,913
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 229,341
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 82,145
HTS_TST Service Delivery Point (Facility): Index testing 2017 941
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,813
HTS_TST Service Delivery Point (Facility): Inpatient 2017 7,022
HTS_TST Service Delivery Point (Facility): Inpatient 2017 17,793
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 5
HTS_TST Service Delivery Point (Facility): Outpatient 2017 51,151
HTS_TST Service Delivery Point (Facility): Outpatient 2017 130,724
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,198
HTS_TST Service Delivery Point (Facility): Pediatric 2017 3,986
HTS_TST Service Delivery Point (Facility): PMTCT 2017 17,589
HTS_TST Service Delivery Point (Facility): PMTCT 2017 72,957
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 4,244
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,063
HTS_TST Sum of Aggregated Age/Sex <15 2017 72,441
HTS_TST Sum of Aggregated Age/Sex <15 2017 27,240
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 156,900
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 54,905
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 229,341
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 82,145
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 903
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 317
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 961
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 358
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 10,153
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 3,648
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 6,236
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,381
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,890
PMTCT_ART Already on ART at beginning of current pregnancy 2017 584
PMTCT_ART New on ART 2017 2,199
PMTCT_ART New on ART 2017 502
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 74,413
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 17,158
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 3,148
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 964
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 723
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 340
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 16
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 12
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 43
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 11
PMTCT_EID Sum of Infant Age disaggregates 2017 3,871
PMTCT_EID Sum of Infant Age disaggregates 2017 1,304
PMTCT_STAT By: Known positives at entry 2017 1,707
PMTCT_STAT By: Known positives at entry 2017 505
PMTCT_STAT By: Number of new positives identified 2017 2,643
PMTCT_STAT By: Number of new positives identified 2017 612
PMTCT_STAT Number of new ANC and L&D clients 2017 78,209
PMTCT_STAT Number of new ANC and L&D clients 2017 18,037
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 74,413
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 17,158
PMTCT_STAT Sum of Positives Status disaggregates 2017 4,350
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,117
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 7
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 14
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 179
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 481
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 13
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 239
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 552
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 458
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,093
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 428
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,060
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 4,657
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 3,404
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 1,564
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,074
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,815
TB_SCREENDX Screen Result: Screened Positive for TB 2017 4,675
TB_SCREENDX Screen Results: Screened Positive for TB 2017 3,418
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 113
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 104
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 4,806
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 4,067
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,412
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,698
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 148
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 156
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 12,891
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 12,782
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 12
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 33
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 191
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 481
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 35
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 264
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 618
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 474
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,167
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 526
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,295
TX_CURR Aggregated Age/Sex: <15 Female 2017 460
TX_CURR Aggregated Age/Sex: <15 Female 2017 3,157
TX_CURR Aggregated Age/Sex: <15 Male 2017 380
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,122
TX_CURR Aggregated Age/Sex: 15+ Female 2017 12,700
TX_CURR Aggregated Age/Sex: 15+ Female 2017 21,507
TX_CURR Aggregated Age/Sex: 15+ Male 2017 5,078
TX_CURR Aggregated Age/Sex: 15+ Male 2017 8,167
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 18,614
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 34,953
TX_CURR Sum of Aggregated Age/Sex <15 2017 840
TX_CURR Sum of Aggregated Age/Sex <15 2017 5,279
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 17,778
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 29,674
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 18,618
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 34,953
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 157
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 630
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 128
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 419
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 6,057
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 9,663
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,822
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 5,797
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 9,164
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 16,509
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 9,164
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 16,509
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 2,220
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 3,139
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 2,009
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 2,816
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 51
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 112
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 38
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 92
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,416
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 1,621
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 504
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 991
TX_PVLS Numerator: Indication: Routine 2017 2,009
TX_PVLS Numerator: Indication: Routine 2017 2,816
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 67
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 125
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 43
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 102
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,551
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,808
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 557
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 1,104
TX_PVLS_den Denominator: Indication: Routine 2017 2,220
TX_PVLS_den Denominator: Indication: Routine 2017 3,139
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 125
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 343
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 97
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 273
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,978
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,509
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,845
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,505
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 7,050
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 9,630
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 10,707
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 14,631
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 189
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 530
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 150
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 422
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7,580
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,504
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,825
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,175